Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 MAR 23 ... ovarian and endometrial cancers. - March
- Patient dosing commenced with cetrorelix in the second efficacy study
of the Phase 3 program in benign prostatic ...
2009 NOV 23 ... - August 17, 2009. Disclosure of results for two Phase 3 studies with cetrorelix in benign prostatic hyperplasia ("BPH"). The efficacy study Z-033 did not ...
2009 JUN 29 ... 3 program in benign prostatic hyperplasia (BPH) with its lead endocrinology compound, cetrorelix pamoate, is scheduled to be completed at the end of this week. Therefore, data analysis ...
2009 JUN 1 ... follicular development in women with severe LH and FSH deficiency; Cetrotide(R) (cetrorelix acetate) to prevent a premature ovulation; Ovitrelle(R) (choriogonadotropin alfa), to ...
2009 NOV 9 ... if these receptors are suitable targets for the treatment with the LHRH antagonist Cetrorelix." "Receptors for LHRH were expressed in all tumor samples and in the TNBC ...
2009 APR 27 ... in monkeys."
"Induced luteolysis with GnRH receptor antagonist (Cetrorelix) resulted in differential regulation of 3949 genes, whereas replacement with exogenous ...
2009 OCT 5 ... binding affinities to the GnRH-I receptor comparable with that of GnRH-I antagonist Cetrorelix. Referring to the cyclic AMP response element reporter gene activation assay, the ...
2009 MAR 9 ... be mediated by DHT- and leptin-induced GnRH release. Accordingly, the GnRH antagonist cetrorelix inhibited DHT- and leptin-induced migration. Our results suggest that androgens ...
2009 MAR 2 ... private fertility centre."
"After stimulation with 225 IU rFSH and Cetrorelix 0.25mg/day, 212 oocyte donors were randomised with sealed envelopes for triggering with ...
2009 JUN 22 ... ovarian stimulation with recombinant FSH."
"A GnRH antagonist, cetrorelix 0.25 mg/day, was started when leading follicle reached 14 mm in diameter until the day ...
2009 MAR 16 ... agreement with AEterna Zentaris GmbH for the development, registration and marketing of cetrorelix pamoate, a luteinizing hormone-releasing hormone (LHRH) antagonist, for the treatment of ...
2009 NOV 9 ... the pheochromocytoma cell line. The GHRH receptor antagonist MZ-4-71 and LHRH antagonist Cetrorelix both significantly reduced cell growth in the adrenocortical cancer cell line," wrote ...
2009 APR 20 ... injections of 5 nmol kisspeptin-54 and pre-administered a GnRH-receptor antagonist (cetrorelix) to rats peripherally treated with kisspeptin-54. Continuous subcutaneous administration ...
2009 JUN 8 ... Blvd., St. Louis, MO 63132, USA.
Keywords: United States, Chapel Hill, Cetrorelix, Drugs, Estradiol, Gonadotropin, Hormones, Obstetrics, Pharmaceuticals, Pregnancy, ...
2009 AUG 24 ... the extension of the Company's North American Phase 3 efficacy study with cetrorelix in benign prostatic hyperplasia ("BPH"). This extension of the study is ...
2008 NOV 3 ... stimulate follicular development in women who are profoundly LH deficient; Cetrotide(R) (cetrorelix acetate) to prevent a premature ovulation; Ovitrelle(R) (choriogonadotropin alfa), to ...
2008 DEC 29 ... "In the present study, we aimed to compare the effects of cetrorelix and leuprolide on endometriosis. This randomized, placebo-controlled, single-blind, ...
2008 NOV 24 ... Trial Research, Hormones, Gonadotropin, Pharmaceuticals, Drugs, Therapy, Treatment, Cetrorelix.
This article was prepared by Biotech Business Week editors from staff ...
2008 SEP 29 ... nM), a GnRH agonist, increased annexin A5 expression in cultured testis cells and that Cetrorelix (100 nM), a GnRH antagonist, inhibited the effect of hCG on annexin A5 expression," ...
